VERNON HILLS, Ill., May 12 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. announced today that the Company will be presenting at the Rodman and Renshaw 3rd Annual Global Healthcare Conference to be held at Le Meridien Beach Plaza Hotel, 22, Avenue Princesse Grace, Monte Carlo, Monaco. Eric L. Sorkin, Immtech’s Chairman and Chief Executive Officer, will give a corporate update on Tuesday, May 16, 2006 at 10:50 a.m. CEDT.
About Immtech Pharmaceuticals
Immtech Pharmaceuticals, Inc. is focused on developing and commercializing drugs to treat infectious diseases, and the Company is expanding its targeted markets by applying its proprietary pharmaceutical platform to treat other disorders. Immtech has advanced clinical programs that include new treatments for Pneumocystis pneumonia, malaria and African sleeping sickness (Trypanosomiasis), and drug development programs for tuberculosis and fungal infections. The Company has worldwide licensing and exclusive commercialization rights to a large library of well-defined compounds from which a pipeline of therapeutic products could be developed. For additional information, please go to http://www.immtechpharma.com.
“Safe Harbor” Statement under the Private Securities Reform Act of 1995: Statements in this press release regarding Immtech Pharmaceuticals, Inc.'s business which are not historical facts are “forward-looking statements” that involve risks and uncertainties. For a discussion of such risks and uncertainties that could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s Annual Report on Form 10-K for the most recently ended fiscal year.
Immtech Pharmaceuticals, Inc.
CONTACT: F. C. Thompson, 1-877-898-8038, for Immtech Pharmaceuticals, Inc.
Web site: http://www.immtechpharma.com/
